Teatis closes seed round with $700K, offering meal replacement for diabetic Americans


Image credit: Teatis

Launched by Japanese serial entrepreneur Hiroshi Takatoh, Teatis offers meal replacement / superfood powders for diabetic consumers mainly in the US. The company announced on Friday that it has secured $700,000 in a seed round. Participating in the round are Genesia Ventures, Ryo Ishizuka (co-founder of Japanese C2C company Mercari), Takuya Noguchi (founder of Japanese men’s skincare D2C brand Bulk Homme), and seven unnamed angel investors. This round follows the company’s angel round announced in June and brings their total funding amount up to over $1 million. Noguchi participated in the previous round.

Focusing on diabetes, one of the most common lifestyle-related diseases among people today, Teatis started offering meal replacements, which contain a lot of superfood ingredients such as seaweed polyphenols, in the US, where about 120 million people are said to have pre- and diabetes. When dissolved in water, it can be drunk as a smoothie or latte with a focus to help curb blood sugar spike, contains no chemicals nor sweeteners but seaweed extract which has been proven to inhibit the absorption of sugar from the intestinal tract and help maintain normal blood sugar levels.

Prior to the official launch, Takatoh revealed Teatis already had about 4,000 pre-registered users in June. Asked these users a try, the company received a lot of feedback that they felt it helped control elevated blood sugar levels. In September, they plan to launch a platform called Teatis RD on Demand, aiming to give users nutrition advice by registered dietitians.

via PR Newswire